Evidence map›Paper›PMID 39380240›Full record

ArticleActa neuropsychiatrica2024

RNA m

Margus Kanarik, Kristi Liiver, Marianna Norden, Indrek Teino, Tõnis Org, Karita Laugus, Ruth Shimmo, Mati Karelson, Mart Saarma, Jaanus Harro

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropsychiatrica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Decoding the role of mNeurochemistry international · 2025
    Review
  4. mEpigenomes · 2025
    Review
  5. An Investigation of the RNA Modification mInternational journal of molecular sciences · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Margus KanarikDivision of Neuropsychopharmacology, Institute of Chemistry, University of Tartu, Tartu, Tartumaa, Estonia.
Kristi LiiverSchool of Natural Sciences and Health, Tallinn University, Tallinn, Harjumaa, Estonia.
Marianna NordenSchool of Natural Sciences and Health, Tallinn University, Tallinn, Harjumaa, Estonia.
Indrek TeinoInstitute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Uusimaa, Finland.
Tõnis OrgInstitute of Genomics, University of Tartu, Tartu, Tartumaa, Estonia.
Karita LaugusDivision of Neuropsychopharmacology, Institute of Chemistry, University of Tartu, Tartu, Tartumaa, Estonia.
Ruth ShimmoSchool of Natural Sciences and Health, Tallinn University, Tallinn, Harjumaa, Estonia.
Mati KarelsonDivision of Molecular Technology, Institute of Chemistry, University of Tartu, Tartu, Estonia.
Mart SaarmaInstitute of Biotechnology, HiLIFE, University of Helsinki, Helsinki, Uusimaa, Finland.
Jaanus HarroDivision of Neuropsychopharmacology, Institute of Chemistry, University of Tartu, Tartu, Tartumaa, Estonia.ORCID https://orcid.org/0000-0002-4484-2096

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Modification of mRNA by methylation is involved in post-transcriptional regulation of gene expression by affecting the splicing, transport, stability and translation of mRNA. Methylation of adenosine at N

Indexed as

Anti-Anxiety AgentsAnxietyBehavior, AnimalBiogenic MonoaminesCorpus StriatumMethyltransferasesPiperazinesAnimalsFemaleGene ExpressionMaleMethylationRatsRats, WistarAnti-Anxiety AgentsBiogenic MonoaminesMethyltransferasesPiperazinesanxietydopaminegene expressionlocomotor activitymRNA m6A methylation

Identifiers

PMID39380240
PMCPMC13130313

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.